{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T13:28:38Z","timestamp":1786973318170,"version":"build-2736575974"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T00:00:00Z","timestamp":1777420800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T00:00:00Z","timestamp":1786924800000},"content-version":"vor","delay-in-days":110,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100008871","name":"Juvenile Diabetes Research Foundation United States of America","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008871","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000274","name":"British Heart Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000274","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000361","name":"Diabetes UK","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000361","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009881","name":"JDRF canada","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100009881","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100009881","name":"Juvenile Diabetes Research Foundation Canada","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009881","id-type":"DOI","asserted-by":"publisher"}]},{"name":"National Institute for Health Research (NIHR) UCLH Biomedical Research Centre","award":["BRC800\/CM\/SC\/101320"],"award-info":[{"award-number":["BRC800\/CM\/SC\/101320"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Adolescence represents a pivotal period for the development of early diabetes-related vascular complications, primarily driven by chronic hyperglycemia and associated metabolic disturbances. Metabolomics provides a promising tool to identify biomarkers reflecting these early changes. The present study compared metabolomic profiles between adolescents with and without type 1 diabetes and assessed the impact of glycemia and short-term treatment with statins and\/or ACE inhibitors on metabolite trajectories. Metabolomic data were obtained via the Nightingale platform from 341 adolescents with type 1 diabetes from the AdDIT study and 81 age- and sex-matched peers without diabetes. Two hundred and forty-nine metabolites, with 45 prioritized due to well-established links with cardiovascular disease- including lipid subfractions, amino acids, ketone bodies, and markers of renal function and inflammation\u2014were measured at a mean age of 14.0\u2009\u00b1\u20091.8 years and re-assessed after 3.5 years in those with diabetes. At baseline, significant differences were observed in glucose, ketone bodies, amino acids, and lipid classes. Over time, adolescents with diabetes showed increases in lipid subfractions, acetoacetate, and GlycA, with HbA1c positively associated with atherogenic lipidome components. Findings from the trial arm provided strong evidence that statins attenuated rises in LDL-cholesterol (1.90 [1.79, 2.01] vs. 2.38 [2.28, 2.49] mmol\/l), and weaker evidence suggestive of a small effect of ACE inhibitors in preserving HDL-cholesterol (1.50 [1.45, 1.54] vs. 1.39 [1.34, 1.43] mmol\/l). These findings suggest widespread glycemia-related metabolomic perturbations in adolescents with type 1 diabetes, partially mitigated by statins and ACE inhibitors, supporting their cardioprotective role.<\/jats:p>\n                  <jats:p>\n                    <jats:italic>Clinical registration<\/jats:italic>\n                    : ClinicalTrials.gov ID NCT01581476 (13\/04\/2012)\n                    <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" xlink:href=\"https:\/\/clinicaltrials.gov\/study\/NCT01581476\" ext-link-type=\"uri\">https:\/\/clinicaltrials.gov\/study\/NCT01581476<\/jats:ext-link>\n                    .\n                  <\/jats:p>","DOI":"10.1038\/s41598-026-50044-w","type":"journal-article","created":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T11:56:21Z","timestamp":1777463781000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Effect of statins and ACE inhibitors on the metabolome in the Adolescent Type 1 Diabetes cardio-renal Intervention Trial (AdDIT) cohort"],"prefix":"10.1038","volume":"16","author":[{"given":"Beatrice","family":"Prampolini","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antoine","family":"Giton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sofia","family":"Frassineti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Benitez-Aguirre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fergus J.","family":"Cameron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria E.","family":"Craig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer J.","family":"Couper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R. Neil","family":"Dalton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Denis","family":"Daneman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth A.","family":"Davis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kim C.","family":"Donaghue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tim W.","family":"Jones","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Farid H.","family":"Mahmud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sally M.","family":"Marshall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H. Andrew","family":"Neil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John E.","family":"Deanfield","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. Loredana","family":"Marcovecchio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott T.","family":"Chiesa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,29]]},"reference":[{"key":"50044_CR1","doi-asserted-by":"publisher","first-page":"696499","DOI":"10.3389\/fped.2021.696499","volume":"9","author":"ST Chiesa","year":"2021","unstructured":"Chiesa, S. T. & Marcovecchio, M. L. Preventing cardiovascular complications in type 1 diabetes: The need for a lifetime approach. Front. Pediatr. 9, 696499. https:\/\/doi.org\/10.3389\/fped.2021.696499 (2021).","journal-title":"Front. Pediatr."},{"issue":"5","key":"50044_CR2","doi-asserted-by":"publisher","first-page":"964","DOI":"10.1210\/jcem-73-5-964","volume":"73","author":"JA Batch","year":"1991","unstructured":"Batch, J. A., Baxter, R. C. & Werther, G. Abnormal regulation of insulin-like growth factor binding proteins in adolescents with insulin-dependent diabetes. J. Clin. Endocrinol. Metab. 73 (5), 964\u2013968. https:\/\/doi.org\/10.1210\/jcem-73-5-964 (1991).","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"5","key":"50044_CR3","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1111\/pedi.12295","volume":"17","author":"MA Clements","year":"2016","unstructured":"Clements, M. A. et al. Hemoglobin A1c (HbA1c) changes over time among adolescent and young adult participants in the T1D exchange clinic registry. Pediatr. Diabetes. 17 (5), 327\u2013336. https:\/\/doi.org\/10.1111\/pedi.12295 (2016).","journal-title":"Pediatr. Diabetes"},{"issue":"8","key":"50044_CR4","doi-asserted-by":"publisher","first-page":"1432","DOI":"10.1111\/pedi.13444","volume":"23","author":"P Bjornstad","year":"2022","unstructured":"Bjornstad, P. et al. ISPAD Clinical Practice Consensus Guidelines 2022: Microvascular and macrovascular complications in children and adolescents with diabetes. Pediatr. Diabetes. 23 (8), 1432\u20131450. https:\/\/doi.org\/10.1111\/pedi.13444 (2022).","journal-title":"Pediatr. Diabetes"},{"issue":"1","key":"50044_CR5","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1111\/pedi.12323","volume":"17","author":"BI Frohnert","year":"2016","unstructured":"Frohnert, B. I. & Rewers, M. J. Metabolomics in childhood diabetes. Pediatr. Diabetes. 17 (1), 3\u201314. https:\/\/doi.org\/10.1111\/pedi.12323 (2016).","journal-title":"Pediatr. Diabetes"},{"issue":"32","key":"50044_CR6","doi-asserted-by":"publisher","first-page":"5426","DOI":"10.1002\/anie.200905579","volume":"49","author":"WJ Griffiths","year":"2010","unstructured":"Griffiths, W. J. et al. Targeted metabolomics for biomarker discovery. Angew Chem. Int. Ed. Engl. 49 (32), 5426\u20135445. https:\/\/doi.org\/10.1002\/anie.200905579 (2010).","journal-title":"Angew Chem. Int. Ed. Engl."},{"key":"50044_CR7","doi-asserted-by":"publisher","unstructured":"Aderemi, A. V., Ayeleso, A. O., Oyedapo, O. O. & Mukwevho, E. Metabolomics: A scoping review of its role as a tool for disease biomarker discovery in selected non-communicable diseases. Metabolites 11 (7). https:\/\/doi.org\/10.3390\/metabo11070418 (2021).","DOI":"10.3390\/metabo11070418"},{"issue":"19","key":"50044_CR8","doi-asserted-by":"publisher","first-page":"2882","DOI":"10.1002\/elps.201300062","volume":"34","author":"C Balderas","year":"2013","unstructured":"Balderas, C. et al. Plasma and urine metabolic fingerprinting of type 1 diabetic children. Electrophoresis 34 (19), 2882\u20132890. https:\/\/doi.org\/10.1002\/elps.201300062 (2013).","journal-title":"Electrophoresis"},{"issue":"3","key":"50044_CR9","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1210\/jc.2015-2640","volume":"101","author":"T Dutta","year":"2016","unstructured":"Dutta, T. et al. Impact of long-term poor and good glycemic control on metabolomics alterations in Type 1 diabetic people. J. Clin. Endocrinol. Metab. 101 (3), 1023\u20131033. https:\/\/doi.org\/10.1210\/jc.2015-2640 (2016).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"50044_CR10","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1186\/s13098-017-0246-9","volume":"9","author":"L Bervoets","year":"2017","unstructured":"Bervoets, L. et al. Metabolic profiling of type 1 diabetes mellitus in children and adolescents: A case-control study. Diabetol. Metab. Syndr. 9, 48. https:\/\/doi.org\/10.1186\/s13098-017-0246-9 (2017).","journal-title":"Diabetol. Metab. Syndr."},{"issue":"1","key":"50044_CR11","doi-asserted-by":"publisher","first-page":"158823","DOI":"10.1016\/j.bbalip.2020.158823","volume":"1866","author":"AIS Sobczak","year":"2021","unstructured":"Sobczak, A. I. S., Pitt, S. J., Smith, T. K., Ajjan, R. A. & Stewart, A. J. Lipidomic profiling of plasma free fatty acids in type-1 diabetes highlights specific changes in lipid metabolism. Biochim. Biophys. Acta Mol. Cell. Biol. Lipids. 1866 (1), 158823. https:\/\/doi.org\/10.1016\/j.bbalip.2020.158823 (2021).","journal-title":"Biochim. Biophys. Acta Mol. Cell. Biol. Lipids"},{"issue":"18","key":"50044_CR12","doi-asserted-by":"publisher","first-page":"1733","DOI":"10.1056\/NEJMoa1703518","volume":"377","author":"ML Marcovecchio","year":"2017","unstructured":"Marcovecchio, M. L. et al. ACE inhibitors and statins in adolescents with type 1 diabetes. N Engl. J. Med. 377 (18), 1733\u20131745. https:\/\/doi.org\/10.1056\/NEJMoa1703518 (2017).","journal-title":"N Engl. J. Med."},{"issue":"6","key":"50044_CR13","doi-asserted-by":"publisher","first-page":"1734","DOI":"10.1161\/hypertensionaha.120.15721","volume":"76","author":"ST Chiesa","year":"2020","unstructured":"Chiesa, S. T. et al. Vascular effects of ACE (angiotensin-converting enzyme) inhibitors and statins in adolescents with type 1 diabetes. Hypertension 76 (6), 1734\u20131743. https:\/\/doi.org\/10.1161\/hypertensionaha.120.15721 (2020).","journal-title":"Hypertension"},{"issue":"6","key":"50044_CR14","doi-asserted-by":"publisher","first-page":"e001759","DOI":"10.1161\/CIRCGENETICS.117.001759","volume":"10","author":"D Kofink","year":"2017","unstructured":"Kofink, D. et al. Statin effects on metabolic profiles. Circulation: Cardiovasc. Genet. 10 (6), e001759. https:\/\/doi.org\/10.1161\/CIRCGENETICS.117.001759 (2017).","journal-title":"Circulation: Cardiovasc. Genet."},{"key":"50044_CR15","doi-asserted-by":"publisher","first-page":"103687","DOI":"10.1016\/j.dib.2019.01.035","volume":"23","author":"LM O\u2019Keeffe","year":"2019","unstructured":"O\u2019Keeffe, L. M. et al. Data on trajectories of measures of cardiovascular health in the Avon Longitudinal Study of Parents and Children (ALSPAC). Data Brief. 23, 103687. https:\/\/doi.org\/10.1016\/j.dib.2019.01.035 (2019).","journal-title":"Data Brief."},{"key":"50044_CR16","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/j.jpeds.2015.11.018","volume":"170","author":"MA Eissa","year":"2016","unstructured":"Eissa, M. A., Mihalopoulos, N. L., Holubkov, R., Dai, S. & Labarthe, D. R. Changes in fasting lipids during puberty. J. Pediatr. 170, 199\u2013205. https:\/\/doi.org\/10.1016\/j.jpeds.2015.11.018 (2016).","journal-title":"J. Pediatr."},{"issue":"2","key":"50044_CR17","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1053\/j.ajkd.2017.06.011","volume":"71","author":"MB Lanktree","year":"2018","unstructured":"Lanktree, M. B., Th\u00e9riault, S., Walsh, M. & Par\u00e9, G. HDL cholesterol, LDL cholesterol, and triglycerides as risk factors for CKD: A mendelian randomization study. Am. J. Kidney Dis. 71 (2), 166\u2013172. https:\/\/doi.org\/10.1053\/j.ajkd.2017.06.011 (2018).","journal-title":"Am. J. Kidney Dis."},{"issue":"2","key":"50044_CR18","doi-asserted-by":"publisher","first-page":"274","DOI":"10.2215\/cjn.02760310","volume":"6","author":"SH Huang","year":"2011","unstructured":"Huang, S. H. et al. Hyperfiltration affects accuracy of creatinine eGFR measurement. Clin. J. Am. Soc. Nephrol. 6 (2), 274\u2013280. https:\/\/doi.org\/10.2215\/cjn.02760310 (2011).","journal-title":"Clin. J. Am. Soc. Nephrol."},{"issue":"1","key":"50044_CR19","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1186\/s12902-022-01062-y","volume":"22","author":"S Tan","year":"2022","unstructured":"Tan, S., Gunendi, Z., Meray, J. & Yetkin, \u0130. The evaluation of muscle strength and architecture in type 1 diabetes mellitus: a cross-sectional study. BMC Endocr. Disord. 22 (1), 153. https:\/\/doi.org\/10.1186\/s12902-022-01062-y (2022).","journal-title":"BMC Endocr. Disord"},{"key":"50044_CR20","doi-asserted-by":"publisher","first-page":"112060","DOI":"10.1016\/j.nut.2023.112060","volume":"112","author":"D Pollakova","year":"2023","unstructured":"Pollakova, D. et al. Muscular involvement in long-term type 1 diabetes: Does it represent an underestimated complication? Nutrition 112, 112060. https:\/\/doi.org\/10.1016\/j.nut.2023.112060 (2023).","journal-title":"Nutrition"},{"key":"50044_CR21","doi-asserted-by":"publisher","first-page":"793446","DOI":"10.3389\/fped.2021.793446","volume":"9","author":"GT Chuang","year":"2021","unstructured":"Chuang, G. T., Tsai, I. J. & Tsau, Y. K. Serum creatinine reference limits in pediatric population-A single center electronic health record-based database in Taiwan. Front. Pediatr. 9, 793446. https:\/\/doi.org\/10.3389\/fped.2021.793446 (2021).","journal-title":"Front. Pediatr."},{"issue":"6","key":"50044_CR22","first-page":"437","volume":"49","author":"M Torres-Tamayo","year":"1997","unstructured":"Torres-Tamayo, M. et al. Lipoprotein(a) levels in children and adolescents with diabetes. Rev. Invest. Clin. 49 (6), 437\u2013443 (1997).","journal-title":"Rev. Invest. Clin."},{"issue":"5","key":"50044_CR23","doi-asserted-by":"publisher","first-page":"1356","DOI":"10.2337\/diacare.26.5.1356","volume":"26","author":"EJ Wiltshire","year":"2003","unstructured":"Wiltshire, E. J., Hirte, C. & Couper, J. J. Dietary fats do not contribute to hyperlipidemia in children and adolescents with type 1 diabetes. Diabetes Care. 26 (5), 1356\u20131361. https:\/\/doi.org\/10.2337\/diacare.26.5.1356 (2003).","journal-title":"Diabetes Care"},{"issue":"1","key":"50044_CR24","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1111\/j.1559-4572.2008.00034.x","volume":"4","author":"S Krishnan","year":"2009","unstructured":"Krishnan, S. & Short, K. R. Prevalence and significance of cardiometabolic risk factors in children with type 1 diabetes. J. Cardiometab Syndr. 4 (1), 50\u201356. https:\/\/doi.org\/10.1111\/j.1559-4572.2008.00034.x (2009).","journal-title":"J. Cardiometab Syndr."},{"issue":"43","key":"50044_CR25","doi-asserted-by":"publisher","first-page":"3559","DOI":"10.1093\/eurheartj\/ehz114","volume":"40","author":"ST Chiesa","year":"2019","unstructured":"Chiesa, S. T. et al. Elevated high-density lipoprotein in adolescents with Type 1 diabetes is associated with endothelial dysfunction in the presence of systemic inflammation. Eur. Heart J. 40 (43), 3559\u20133566. https:\/\/doi.org\/10.1093\/eurheartj\/ehz114 (2019).","journal-title":"Eur. Heart J."},{"issue":"1","key":"50044_CR26","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1186\/s12933-017-0570-2","volume":"16","author":"M Heier","year":"2017","unstructured":"Heier, M. et al. Reduced HDL function in children and young adults with type 1 diabetes. Cardiovasc. Diabetol. 16 (1), 85. https:\/\/doi.org\/10.1186\/s12933-017-0570-2 (2017).","journal-title":"Cardiovasc. Diabetol."},{"issue":"3","key":"50044_CR27","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1016\/j.plefa.2003.11.001","volume":"70","author":"T Fukao","year":"2004","unstructured":"Fukao, T., Lopaschuk, G. D. & Mitchell, G. A. Pathways and control of ketone body metabolism: on the fringe of lipid biochemistry. Prostaglandins Leukot. Essent. Fat. Acids. 70 (3), 243\u2013251. https:\/\/doi.org\/10.1016\/j.plefa.2003.11.001 (2004).","journal-title":"Prostaglandins Leukot. Essent. Fat. Acids"},{"issue":"6","key":"50044_CR28","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1002\/(sici)1520-7560","volume":"15","author":"L Laffel","year":"1999","unstructured":"Laffel, L. Ketone bodies: A review of physiology, pathophysiology and application of monitoring to diabetes. Diabetes Metab. Res. Rev. 15 (6), 412\u2013426. https:\/\/doi.org\/10.1002\/(sici)1520-7560 (1999). 8.","journal-title":"Diabetes Metab. Res. Rev."},{"issue":"11","key":"50044_CR29","doi-asserted-by":"publisher","first-page":"1184","DOI":"10.1016\/S0022-2275(20)34462-X","volume":"25","author":"SE Hall","year":"1984","unstructured":"Hall, S. E., Wastney, M. E., Bolton, T. M., Braaten, J. T. & Berman, M. Ketone body kinetics in humans: The effects of insulin-dependent diabetes, obesity, and starvation. J. Lipid Res. 25 (11), 1184\u20131194 (1984).","journal-title":"J. Lipid Res."},{"issue":"Pt 3","key":"50044_CR30","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1042\/bj3380569","volume":"338","author":"FG Hegardt","year":"1999","unstructured":"Hegardt, F. G. Mitochondrial 3-hydroxy-3-methylglutaryl-CoA synthase: a control enzyme in ketogenesis. Biochem. J. 338 (Pt 3), 569\u2013582 (1999).","journal-title":"Biochem. J."},{"issue":"6","key":"50044_CR31","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1111\/micc.12053","volume":"20","author":"TE Close","year":"2013","unstructured":"Close, T. E. et al. Diabetic ketoacidosis elicits systemic inflammation associated with cerebrovascular endothelial cell dysfunction. Microcirculation 20 (6), 534\u2013543. https:\/\/doi.org\/10.1111\/micc.12053 (2013).","journal-title":"Microcirculation"},{"issue":"1","key":"50044_CR32","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1159\/000369702","volume":"35","author":"P Kanikarla-Marie","year":"2015","unstructured":"Kanikarla-Marie, P. & Jain, S. K. Hyperketonemia (acetoacetate) upregulates NADPH oxidase 4 and elevates oxidative stress, ICAM-1, and monocyte adhesivity in endothelial cells. Cell. Physiol. Biochem. 35 (1), 364\u2013373. https:\/\/doi.org\/10.1159\/000369702 (2015).","journal-title":"Cell. Physiol. Biochem."},{"key":"50044_CR33","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1016\/j.freeradbiomed.2016.03.020","volume":"95","author":"P Kanikarla-Marie","year":"2016","unstructured":"Kanikarla-Marie, P. & Jain, S. K. Hyperketonemia and ketosis increase the risk of complications in type 1 diabetes. Free Radic Biol. Med. 95, 268\u2013277. https:\/\/doi.org\/10.1016\/j.freeradbiomed.2016.03.020 (2016).","journal-title":"Free Radic Biol. Med."},{"issue":"1","key":"50044_CR34","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.clnu.2009.09.001","volume":"29","author":"SL Hebert","year":"2010","unstructured":"Hebert, S. L. & Nair, K. S. Protein and energy metabolism in type 1 diabetes. Clin. Nutr. 29 (1), 13\u201317. https:\/\/doi.org\/10.1016\/j.clnu.2009.09.001 (2010).","journal-title":"Clin. Nutr."},{"issue":"7\u20138","key":"50044_CR35","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1007\/s00018-005-5410-y","volume":"63","author":"S Jitrapakdee","year":"2006","unstructured":"Jitrapakdee, S., Vidal-Puig, A. & Wallace, J. C. Anaplerotic roles of pyruvate carboxylase in mammalian tissues. Cell. Mol. Life Sci. 63 (7\u20138), 843\u2013854. https:\/\/doi.org\/10.1007\/s00018-005-5410-y (2006).","journal-title":"Cell. Mol. Life Sci."},{"issue":"5","key":"50044_CR36","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1373\/clinchem.2014.232918","volume":"61","author":"JD Otvos","year":"2015","unstructured":"Otvos, J. D. et al. GlycA: A composite nuclear magnetic resonance biomarker of systemic inflammation. Clin. Chem. 61 (5), 714\u2013723. https:\/\/doi.org\/10.1373\/clinchem.2014.232918 (2015).","journal-title":"Clin. Chem."},{"issue":"1","key":"50044_CR37","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1186\/s12967-017-1321-6","volume":"15","author":"MA Connelly","year":"2017","unstructured":"Connelly, M. A., Otvos, J. D., Shalaurova, I., Playford, M. P. & Mehta, N. N. GlycA, a novel biomarker of systemic inflammation and cardiovascular disease risk. J. Transl Med. 15 (1), 219. https:\/\/doi.org\/10.1186\/s12967-017-1321-6 (2017).","journal-title":"J. Transl Med."},{"issue":"4","key":"50044_CR38","doi-asserted-by":"publisher","first-page":"e024380","DOI":"10.1161\/jaha.121.024380","volume":"11","author":"ST Chiesa","year":"2022","unstructured":"Chiesa, S. T. et al. Glycoprotein acetyls: a novel inflammatory biomarker of early cardiovascular risk in the young. J. Am. Heart Assoc. 11 (4), e024380. https:\/\/doi.org\/10.1161\/jaha.121.024380 (2022).","journal-title":"J. Am. Heart Assoc."},{"key":"50044_CR39","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1186\/1471-2431-9-79","volume":"9","author":"Group AtDc-rITR","year":"2009","unstructured":"Adolescent type 1 Diabetes cardio-renal Intervention Trial Research Group. Adolescent type 1 diabetes cardio-renal intervention trial (AdDIT). BMC Pediatr. 9, 79. https:\/\/doi.org\/10.1186\/1471-2431-9-79 (2009).","journal-title":"BMC Pediatr."},{"issue":"9","key":"50044_CR40","doi-asserted-by":"publisher","first-page":"1963","DOI":"10.2337\/dc18-1125","volume":"41","author":"ML Marcovecchio","year":"2018","unstructured":"Marcovecchio, M. L. et al. Renal and cardiovascular risk according to tertiles of urinary albumin-to-creatinine ratio: The Adolescent Type 1 Diabetes cardio-renal Intervention Trial (AdDIT). Diabetes Care. 41 (9), 1963\u20131969. https:\/\/doi.org\/10.2337\/dc18-1125 (2018).","journal-title":"Diabetes Care"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-50044-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-50044-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-50044-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T13:04:10Z","timestamp":1786971850000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-50044-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,29]]},"references-count":40,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["50044"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-50044-w","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,29]]},"assertion":[{"value":"13 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"25681"}}